Komori
Adjuvant Holdings (4929) · TargetAdvancedLatest Earnings (2026-10-21): "Other"

Improving Revenue and Operating Profit Margin

First written in FY2016. 4 of 26 entries say "Advanced", first in FY2021-Q1. Latest entry: 2026-10-21.

26entries
11years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018OtherFY2023-Q1 – 2026-04-172016: 120162017: 120172018: 120182019: 120192020: 320202021: 220212022: 320222023: 420232024: 320242025: 120252026: 62026
Same theme, other companies
Management Indicators Focused on Sales Growth and ProfitabilityA theme 186 companies write about · 4 as a headwind · 184 as a tailwind

26 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「As a result, we forecast consolidated net sales of ¥4,052 million, up 6.3% from the current fiscal year, operating income of ¥50 million, down 70.2%, ordinary income of ¥52 million, down 74.0%, and net income attributable to owners of the parent of ¥24 million, down 82.7%.」

    For the next fiscal year, the Company has set targets of ¥4,052 million in net sales, ¥50 million in operating income, ¥52 million in ordinary income and ¥24 million in net income. It has also presented medium- to long-term targets, including net sales of ¥4.77 billion for fiscal 2027 and at least ¥6 billion for fiscal 2030.
  2. FY2026-H1Lower interim net sales, shift to an operating loss, shift to an ordinary lossAnnual report

    「Consolidated net sales for the interim consolidated accounting period were ¥1,855 million, down 10.8% year on year. The decline in gross profit resulting from lower net sales could not be offset by reductions in selling, general and administrative expenses, including research and development, IT-related, and outsourced service expenses. As a result, the company posted an operating loss of ¥21 million, compared with operating income of ¥55 million in the same period of the previous year, and an ordinary loss of ¥15 million, compared with ordinary income of ¥55 million, due in part to interest and dividend income.」

    Interim net sales declined 10.8% year on year, while operating and ordinary results turned from profit in the same period of the previous year to losses. The company states that reductions in selling, general and administrative expenses could not offset the decline in gross profit.
  3. FY2025-H1Lower interim net sales, return to operating and net profitabilityAnnual report

    「Consolidated net sales for the interim consolidated accounting period were ¥2,079 million, down 6.1% year on year. Despite efforts to improve the operating environment through online channels and a sales management platform, thereby making sales activities more efficient, and activities to promote adoption among employees, net sales declined. In terms of profit, lower advertising, sales promotion, and research and development expenses despite lower net sales resulted in operating income of ¥55 million, compared with an operating loss of ¥92 million in the same period of the previous year. Foreign exchange losses and dividend income, among other factors, resulted in ordinary income of ¥55 million, compared with an ordinary loss of ¥87 million. In addition, the recognition of an extraordinary gain of ¥12 million on the transfer of investment securities resulted in interim net income attributable to owners of the parent of ¥18 million, compared with an interim net loss attributable to owners of the parent of ¥140 million.」

    Interim net sales declined 6.1% year on year, while operating income turned from a loss of ¥92 million to income of ¥55 million, ordinary income turned from a loss of ¥87 million to income of ¥55 million, and interim net income attributable to owners of the parent turned from a loss of ¥140 million to income of ¥18 million.
  4. FY2025-Q1Slight decline in net sales, return to operating profitability, return to net profitabilityAnnual report

    「Consolidated net sales for the first quarter of the current consolidated cumulative period were ¥1,062 million, down 1.0% year on year. Although the company conducted sales activities more efficiently by using online channels that had become standard and introducing and operating a sales management platform, net sales declined. In terms of profit, lower advertising, sales promotion, and research and development expenses despite lower net sales resulted in operating income of ¥1 million, compared with an operating loss of ¥23 million in the same period of the previous year. Foreign exchange gains and dividend income, among other factors, resulted in ordinary income of ¥24 million, compared with an ordinary loss of ¥27 million. Quarterly net income attributable to owners of the parent was ¥13 million, compared with a quarterly net loss attributable to owners of the parent of ¥43 million.」

    First-quarter net sales declined 1.0% year on year, while operating income turned from a loss of ¥23 million to income of ¥1 million, ordinary income turned from a loss of ¥27 million to income of ¥24 million, and quarterly net income attributable to owners of the parent turned from a loss of ¥43 million to income of ¥13 million.
  5. FY2024-Q3Slight increase in net sales, lower operating income, shift to a net lossAnnual report

    「Consolidated net sales for the first nine months of the current consolidated cumulative period were ¥3,500 million, up 0.6% year on year. Despite higher net sales, increases in inventory write-downs, advertising, communication, travel and transportation, and depreciation expenses, as well as a loss on cancellation of insurance policies, resulted in operating income of ¥94 million, compared with ¥242 million in the same period of the previous year, and ordinary income of ¥101 million, compared with ¥273 million. In addition, the absence of the ¥263 million gain on the sale of investment securities recorded in the same period of the previous year resulted in a quarterly net loss attributable to owners of the parent of ¥16 million, compared with quarterly net income attributable to owners of the parent of ¥334 million.」

    For the first nine months, net sales increased 0.6% year on year, while operating income and ordinary income declined, and quarterly net income attributable to owners of the parent turned into a loss of ¥16 million.
  6. FY2024-Q2Higher first-half net sales, shift to an operating lossAnnual report

    「Consolidated net sales for the first half of the current consolidated cumulative period were ¥2,213 million, up 1.9% year on year. As sales activities returned toward pre-pandemic levels, the company conducted them more efficiently by also using online channels that had become standard, and strengthened support for Adjuvant salons, resulting in higher sales. Despite higher net sales, increases in inventory write-downs, advertising, communication, research and development, and sales promotion expenses, as well as a loss on cancellation of insurance policies, resulted in an operating loss of ¥92 million, compared with operating income of ¥33 million in the same period of the previous year, and an ordinary loss of ¥87 million, compared with ordinary income of ¥65 million.」

    First-half net sales increased 1.9% year on year, while operating and ordinary results turned from profit in the same period of the previous year to losses. Higher inventory write-downs, advertising, communication, research and development, and sales promotion expenses are cited as factors affecting profit.
  7. FY2024-Q1Higher net sales, shift to an operating lossAnnual report

    「Consolidated net sales for the first quarter of the current consolidated cumulative period were ¥1,073 million, up 3.7% year on year. Despite higher net sales, a lower gross profit margin, higher sales promotion, advertising, personnel, and research and development expenses, and the recognition of a loss on cancellation of insurance policies resulted in an operating loss of ¥23 million, compared with operating income of ¥24 million in the same period of the previous year, and an ordinary loss of ¥27 million, compared with ordinary income of ¥43 million.」

    Net sales increased 3.7% year on year, while operating income and ordinary income turned from profit in the same period of the previous year to losses.
  8. FY2023Setting the next plan and disclosing results against the previous year’s targetsAnnual report

    「The initial plan for consolidated net sales and the consolidated operating margin for the current consolidated fiscal year called for achieving ¥5,405 million and 4.6%, respectively. As described in “a. Business Results, etc., 2) Analysis of Business Results,” actual consolidated net sales were ¥4,377 million, down 19% from the initial plan, while the consolidated operating margin was 5.3%, up 0.7 percentage points from the initial plan. For next-period net sales, the company will launch 3 skincare lines and 3 haircare lines in its professional beauty products business and work to expand sales. It will also pursue EC activities actively to make up for the delay in the fiscal year ending March 2023. As a result, the company plans consolidated net sales of ¥5,082 million, up 16.1% from the current period; consolidated operating income of ¥151 million, down 35.1%; consolidated ordinary income of ¥141 million, down 46.9%; and net income attributable to owners of the parent of ¥76 million, down 81.0%.」

    Against the previous year’s net sales plan of ¥5,405 million, actual net sales were ¥4,377 million, while the operating margin exceeded the plan. For the next period, the company set targets including net sales of ¥5,082 million and operating income of ¥151 million, based on product launches and EC activities.
  9. FY2023-Q3Lower net sales and operating income, slight increase in net incomeAnnual report

    「As a result of continuing operations while taking sufficient precautions to prevent the spread of COVID-19, including using online channels amid ongoing restrictions on sales activities, net sales for the first nine months of the current consolidated cumulative period were ¥3,479 million, down 1.8% year on year. See the overview of net sales by segment for details. The number of Adjuvant salons in operation was 8,082, an increase of 500 from the same period of the previous year. In terms of profit, lower net sales and higher sales promotion, advertising, and research and development expenses resulted in operating income of ¥242 million, down 48.6% year on year, and ordinary income of ¥273 million, down 43.0%. In addition, the recognition of an extraordinary gain of ¥263 million on the transfer of investment securities resulted in quarterly net income attributable to owners of the parent of ¥334 million, up 0.9% year on year.」

    For the first nine months, net sales, operating income, and ordinary income were below the same period of the previous year, while quarterly net income attributable to owners of the parent increased 0.9% year on year due to the extraordinary gain of ¥263 million on the transfer of investment securities.
  10. FY2023-Q2Lower net sales and operating income, higher net incomeAnnual report

    「Net sales for the first half of the current consolidated cumulative period were ¥2,171 million, down 3.4% year on year. Lower net sales and higher advertising, personnel, and research and development expenses resulted in operating income of ¥33 million, down 87.4% year on year, and ordinary income of ¥65 million, down 76.0%. In addition, the recognition of an extraordinary gain of ¥263 million on the transfer of investment securities resulted in quarterly net income attributable to owners of the parent of ¥207 million, up 20.7% year on year.」

    While net sales, operating income, and ordinary income were below the same period of the previous year, quarterly net income attributable to owners of the parent increased due to the extraordinary gain of ¥263 million on the transfer of investment securities.
  11. FY2023-Q1Lower net sales and operating income, higher net incomeAnnual report

    「Net sales for the first quarter of the current consolidated cumulative period were ¥1,035 million, down 9.1% year on year. Although the gross profit margin improved, lower net sales and higher advertising, personnel, and research and development expenses resulted in operating income of ¥24 million, down 80.8% year on year, and ordinary income of ¥43 million, down 66.3%. In addition, the recognition of an extraordinary gain of ¥263 million on the transfer of investment securities resulted in quarterly net income attributable to owners of the parent of ¥198 million, up 130.4% year on year.」

    While net sales and operating income were below the same period of the previous year, quarterly net income attributable to owners of the parent increased due to the recognition of an extraordinary gain on the transfer of investment securities.
  12. FY2022ReframedAnnual report

    「We formulated a medium-term management plan ending in the fiscal year ending March 2025. Over this three-year period, we will first work to enhance corporate value to meet the Prime Market listing criteria.」

    After withdrawing the previous medium-term management plan, the company shifted to a new three-year plan ending in the fiscal year ending March 2025, reorganizing its focus around meeting the Prime Market listing criteria and enhancing corporate value. It also presented next-plan targets including consolidated net sales of ¥5,405 million and operating income of ¥248 million.
  13. FY2021SoftenedAnnual report

    「However, after taking into account changes in the domestic and overseas business environment since the plan was formulated and the progress of the company’s results for the fiscal year ending March 2021, we determined that achieving the final-year targets of consolidated net sales of ¥10 billion, operating income of ¥2 billion, and an operating margin of more than 20% would be difficult. Accordingly, we decided to withdraw the current medium-term management plan.」

    The company withdrew the medium-term management plan targeting consolidated net sales of ¥10 billion, operating income of ¥2 billion, and an operating margin of more than 20% for the fiscal year ending March 2023. It stated that a new medium-term management plan would be announced after formulation, and the previous numerical targets have not been maintained.
  14. FY2021-Q3AdvancedAnnual report

    「As a result, net sales for the first nine months of the current consolidated cumulative period were ¥3,752 million, up 3.7% year on year. In terms of profit, higher sales following the launch of new products and lower personnel, travel, and transportation expenses resulted in operating income of ¥254 million, compared with an operating loss of ¥80 million in the same period of the previous year, and ordinary income of ¥271 million, compared with an ordinary loss of ¥53 million. However, because the company recorded an impairment loss of ¥100 million on investment securities as an extraordinary loss in the second quarter, quarterly net income attributable to owners of the parent was ¥104 million, compared with a quarterly net loss attributable to owners of the parent of ¥85 million in the same period of the previous year.」

    For the first nine months, net sales increased 3.7% year on year, while operating results turned from a loss of ¥80 million to income of ¥254 million and ordinary results turned from a loss of ¥53 million to income of ¥271 million. The launch of new products and lower personnel, travel, and transportation expenses are cited as specific drivers of the improvement.
  15. FY2021-Q2AdvancedAnnual report

    「Net sales for the first half of the current consolidated cumulative period were ¥2,195 million, down 0.4% year on year. In terms of profit, improved gross profit resulting from lower valuation and disposal losses on inventories, along with lower sales promotion expenses, travel expenses, and transportation expenses, resulted in an operating loss of ¥0 million, compared with an operating loss of ¥239 million in the same period of the previous year, and ordinary income of ¥7 million, compared with an ordinary loss of ¥218 million.」

    Net sales declined only 0.4% year on year, while the operating loss narrowed from ¥239 million to ¥0 million and ordinary income turned positive, from an ordinary loss of ¥218 million to ordinary income of ¥7 million.
  16. FY2021-Q1AdvancedAnnual report

    「Net sales for the first quarter of the current consolidated cumulative period were ¥1,085 million, up 8.6% year on year. See the overview of net sales by segment for details. In terms of profit, higher net sales and lower selling expenses, travel expenses, and transportation expenses resulted in an operating loss of ¥7 million, compared with an operating loss of ¥170 million in the same period of the previous year; an ordinary loss of ¥6 million, compared with an ordinary loss of ¥164 million; and a quarterly net loss attributable to owners of the parent of ¥5 million, compared with a quarterly net loss attributable to owners of the parent of ¥140 million.」

    First-quarter net sales increased 8.6% year on year, while the operating loss narrowed from ¥170 million to ¥7 million. However, no target for achieving the operating margin was presented.
  17. FY2020First-year plan shortfall and improvement plan for the following yearAnnual report

    「The initial plan for consolidated net sales and the consolidated operating margin for the current consolidated fiscal year called for achieving ¥5,647 million and 2.3%, respectively. Actual results were consolidated net sales of ¥4,674 million, down 17.2% from the initial plan, and a consolidated operating margin of △4.0%, down 6.3 percentage points from the initial plan. To improve these indicators, the plan for the fiscal year ending March 2021 called for higher revenue through active promotional activities and growth in skincare and haircare. In the second half, the company planned to launch haircare products using patent-pending ingredients to increase sales.」

    For the first year of the five-year medium-term management plan, the company disclosed consolidated net sales and operating margin below the initial plan. For the fiscal year ending March 2021, it presented an improvement plan involving promotions, product launches using patent-pending ingredients, increased staffing, and enhanced research and development.
  18. FY2019RaisedAnnual report

    「For the fiscal year ending March 2023, the final year of the five-year medium-term plan, we aim to achieve the following management targets: consolidated net sales of ¥10 billion and a consolidated operating margin of 20%.」

    In addition to the previous qualitative targets of higher net sales and operating margin, the company set numerical, time-bound targets of consolidated net sales of ¥10 billion and a consolidated operating margin of 20% by the fiscal year ending March 2023.
  19. FY2018RestatedAnnual report

    「As management indicators, we place importance on each profit measure representing the earning power of the business and company, with a particular focus on increasing net sales and the operating margin.」

    The company continues to use higher net sales and operating margin as management indicators.
  20. FY2017RestatedAnnual report

    「As management indicators, we place importance on each profit measure representing the earning power of the business and company, with a particular focus on increasing net sales and the operating margin.」

    The company continues to use higher net sales and operating margin as management indicators.
  21. FY2016First statedAnnual report

    「As management indicators, we place importance on each profit measure representing the earning power of the business and company, with a particular focus on increasing net sales and the operating margin.」

    The company identifies these as key management indicators without presenting numerical targets.
Moved together

"Expansion in the Number of ADJUVANT Salons in Japan" moved the same way as this thread, in the same document, in 5 of its 26 moves.

544332★123456
  1. ★This thread
  2. 1Expansion in the Number of ADJUVANT Salons in Japan5×
  3. 2Hair Aging Care Through Joint Research with RIKEN and Other Institutions4×
  4. 3Accelerating the development of in-house-formulated, high-performance products through the establishment of a new research institute4×
  5. 4Expanding the Product Lineup Toward Total Beauty Solutions3×
  6. 5Strengthening the MAP system and consulting sales through the acquisition of エクシードシステム3×
  7. 6Strengthening Consultative Sales Using the MAP System2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview It last moved in the Earnings of 2026-10-21: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Improving Revenue and Operating Profit Margin | ADJUVANT HOLDINGS CO.,LTD. (4929) | Komori